サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：安全注射器の世界市場-2023年～2030年
市場調査レポート
商品コード
1373385

安全注射器の世界市場-2023年～2030年

Global Safety Syringes Market - 2023-2030
出版日: | 発行: DataM Intelligence | ページ情報: 英文 187 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
安全注射器の世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 187 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

安全注射器は、ヘルスケアワーカー等への針刺し損傷のリスクを軽減するための安全機構を内蔵した注射器です。安全注射器の注射針は、取り外し可能なものと永久的に取り付けられるものがあります。

安全針は安全注射器と同じ機能を果たしますが、保護機構は注射器ではなく針の一部です。ほとんどの効果的な安全注射器は、再使用および針刺し防止機能を備えています。安全注射器は、さらに安全機構を備えた注射器です。

市場力学：促進要因・抑制要因

針刺し損傷件数の増加

針刺し損傷件数の増加は、安全注射器の需要を増加させ、医療従事者の焦点を従来の注射器から安全注射器へとシフトさせることにより、市場の成長を促進すると予想されます。

例えば、NIHが2022年に発表した報告書によると、世界中の医療従事者の間で針刺し損傷（NSI）やその他の経皮損傷（Pis）が年間60万～80万件発生していると推定されています。

さらに、2023年にベクトン・ディッキンソン社が提供したデータによると、米国では毎年38万5,000人のヘルスケアワーカーが、欧州では100万人以上のヘルスケアワーカーが、針やシャープの事故によって経皮的損傷を経験していると推定されています。従って、針刺し損傷件数の増加が市場成長の原動力になると予想されます。

抑制要因

注射器に関連する高コスト

従来の注射器と比較した場合、安全注射器のコストが高いことが市場成長の妨げになると予想されます。コストが高いのは、安全機能が組み込まれているためと考えられます。規制当局の承認がないことや、代替ドラッグデリバリーシステムの存在が市場成長の妨げになると予想されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 針刺し損傷件数の増加
    • 抑制要因
      • 安全注射器に関連する高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 格納式安全注射器
    • 手動式
    • 自動式
  • 非格納式安全注射器
    • スライディングニードルカバー注射器
    • シースチューブ注射器
    • ヒンジ式ニードルカバー注射器

第8章 用途別

  • 糖尿病
  • 結核
  • HIV
  • 肝炎
  • その他

第9章 エンドユーザー別

  • 病院
  • 診療所
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Becton Dickinson & Company
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Thermo Fisher Scientific.
  • Retractable Technologies, Inc.
  • Terumo Corporation
  • Cardinal Health
  • B. Braun Melsungen AG
  • Revolutions Medical
  • NIPRO Medical Corporation
  • Sol-Millennium Inc.
  • AdvaCare Pharma

第13章 付録

目次
Product Code: MD2026

Overview

A safety syringe is a syringe with a built-in safety mechanism to reduce the risk of needlestick injuries to healthcare workers and others. The needle on a safety syringe can be detachable or permanently attached.

Safety needles serve the same functions as safety syringes, but the protective mechanism is a part of the needle rather than the syringe. Most effective safety syringes have reuse and needlestick prevention features. Safety syringes are syringes that additionally consist of a safety mechanism.

Market Dynamics: Drivers & Restraints

Increase in the number of needlestick injuries

The increase in the number of needlestick injuries is expected to drive market growth by increasing the demand for safety syringes and shifting the focus of healthcare workers from conventional syringes to safety syringes.

For instance, according to a report published by NIH in 2022, it is estimated that 600,000 to 800,000 needlestick injuries (NSIs) and other percutaneous injuries (Pis) occur annually among healthcare workers around the globe.

Additionally, according to the data provided by Becton Dickinson in 2023, every year it is estimated that 385,000 healthcare workers in the United States and more than 1 million healthcare workers in Europe experience a percutaneous injury each year as a result of accidents with needles or sharps. Thus, an increase in the number of needlestick injuries is expected to drive the market growth.

Restraint

High costs associated with the syringes

The high costs of the safety syringes when compared to the conventional syringes are expected to hamper the market growth. The high cost can be due to the safety features that are incorporated. The lack of regulatory approvals and the presence of alternative drug delivery systems are expected to hamper the market growth.

Segment Analysis

The global safety syringes market is segmented based on product type, application, end-user and region.

Retractable safety syringes segment accounted for 39.8% of the market share

Retractable safety syringes are expected to hold a dominant share in the global safety syringes market share due to their advantages over the other types of safety syringes. The Retractable Safety Syringe works in just the same way as a classic syringe, but it automatically retracts the needle once the injection is completed.

They use a spring-loaded system or a manual system for retraction. They prevent cross-contamination and the spread of blood-borne infections. Manual retractable syringes are designed to prioritize safety and minimize the risk of needlestick injuries. Retractable needle safety syringes are mostly accepted over typical syringes and so possess substantial potential for growth. Thus, the retractable safety syringe segment is expected to hold the dominant share in the market.

Geographical Analysis

North America is expected to hold a significant position in the global safety syringes market share

North America holds a dominant share of the safety syringes market owing to the increase in the number of chronic diseases such as diabetes and tuberculosis in the region. The presence of a large number of medical device and disposables manufacturers is also expected to drive market growth in the region.

For instance, according to the report by the Pan American Health Organization in 2022, it is estimated that 62 million people of Americans are suffering from diabetes.

Safety insulin syringe where the needle retracts into the barrel of the syringe after administration, and lowers the risk of needlestick injury. A safety insulin syringe with a shield that slides over the needle lowers the risk of needlestick injury.

For instance, according to WHO, it is estimated that 10.6 million people who fall ill with TB worldwide in 2021 an increase of 4.5% from 10.1 million million in 2020. Thus, an increase in the number of chronic diseases is expected to drive the market growth.

COVID-19 Impact Analysis:

The COVID-19 has impacted the safety syringes market positively. With the increase in the number of vaccinations, the use of advanced safety syringes has been increased. The investments in safety syringe manufacturing have been increased. The vaccinations are made easy without any harm or infection to the patients with the safety syringes.

Competitive Landscape

The leading companies with a significant market share include: Becton Dickinson & Company, Thermo Fisher Scientific., Retractable Technologies, Inc., Terumo Corporation, Cardinal Health, B. Braun Melsungen AG, Revolutions Medical, NIPRO Medical Corporation, Sol-Millennium Inc., and AdvaCare Pharma among others.

Key Developments

  • On February 23, 2023, The FDA approved Zephyrus Innovations' Aeroject 3ml safety syringe which has an internal mechanism that retracts the needle inside the syringe after activation.
  • On October 11, 2021, Datwyler and Roncadelle developed a new safety syringe.

Why Purchase the Report?

  • To visualize the global safety syringes market segmentation based on product type, application, end-user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of safety syringes market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global safety syringes market report would provide approximately 59 tables, 61 figures, and 187 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increase in the number of needlestick injuries
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. High costs associated with the safety syringe
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Retractable Safety Syringes *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Manual
    • 7.2.4. Automatic
  • 7.3. Non-Retractable Safety Syringes
    • 7.3.1. Sliding Needle Cover Syringes
    • 7.3.2. Sheathing Tube Syringes
    • 7.3.3. Hinged Needle Cover Syringes

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diabetes *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Tuberculosis
  • 8.4. HIV
  • 8.5. Hepatitis
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Becton Dickinson & Company *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Thermo Fisher Scientific.
  • 12.3. Retractable Technologies, Inc.
  • 12.4. Terumo Corporation
  • 12.5. Cardinal Health
  • 12.6. B. Braun Melsungen AG
  • 12.7. Revolutions Medical
  • 12.8. NIPRO Medical Corporation
  • 12.9. Sol-Millennium Inc.
  • 12.10. AdvaCare Pharma

LIST NOT EXHAUSTIVE.

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us